Chiauranib Recruiting Phase 3 Trials for Chiauranib / Relapsed or Refractory / Paclitaxel / Ovarian Cancer Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04921527Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer